Evidence map›Paper›PMID 37892816›Full record

ArticleJournal of clinical medicine2023

Survival Analysis of Hospital Length of Stay of COVID-19 Patients in Ilam Province, Iran: A Retrospective Cross-Sectional Study.

Khalil Momeni, Mehdi Raadabadi, Jamil Sadeghifar, Ayoub Rashidi, Zahra Toulideh, Zahra Shoara, Morteza Arab-Zozani

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Khalil MomeniDepartment of Health Economics and Management, School of Health, Ilam University of Medical Sciences, Ilam 6931851147, Iran.
Mehdi RaadabadiHealth Policy and Management Research Center, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd 8916978477, Iran.
Jamil SadeghifarHealth and Environment Research Center, Ilam University of Medical Sciences, Ilam 6931851147, Iran.
Ayoub RashidiDepartment of Health Economics and Management, Ilam University of Medical Sciences, Ilam 6931851147, Iran.
Zahra ToulidehDepartment of Health Economics and Management, Ilam University of Medical Sciences, Ilam 6931851147, Iran.
Zahra ShoaraDepartment of Health Economics and Management, Ilam University of Medical Sciences, Ilam 6931851147, Iran.
Morteza Arab-ZozaniSocial Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand 9717853577, Iran.ORCID 0000-0001-7223-6707

Funding

Medical University of Ilam 1401.119
6 · The paper itself

Abstract

Knowledge of the length of hospitalization of patients infected with coronavirus disease 2019 (COVID-19), its characteristics, and its related factors creates a better understanding of the impact of medical interventions and hospital capacities. Iran is one of the countries with the most deaths in the world (146,321 total deaths; 5 September 2023) and ranks first among the countries of the Middle East and the EMRO. Analysis of confirmed COVID-19 patients' hospital length of stay in Ilam Province can be informative for decision making in other provinces of Iran. This study was conducted to analyze the survival of COVID-19 patients and the factors associated with COVID-19 deaths in the hospitals of Ilam Province. This is a retrospective cross-sectional study. Data from confirmed COVID-19 cases in Ilam Province were obtained from the SIB system in 2019. The sample size was 774 COVID-19-positive patients from Ilam Province. Measuring survival and risk probabilities in one-week intervals was performed using Cox regression. Most patients were male (55.4%) and 55.3% were over 45 years old. Of the 774 patients, 87 (11.2%) died during the study period. The mean hospital length of stay was 5.14 days. The median survival time with a 95% confidence interval was four days. The probability of survival of patients was 80%, 70%, and 38% for 10, 20, and 30 days of hospital stay, respectively. There was a significant relationship between the survival time of patients with age, history of chronic lung diseases, history of diabetes, history of heart diseases, and hospitalization in ICU (

Indexed as

COVID-19Cox regressionhospital length of stayIlamIransurvival analysis

Identifiers

PMID37892816
PMCPMC10607624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.